An underground economy for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.
Separately, a flourishing market exists on Telegram, where communities with numerous of members share comparison photos, injection guides and claims of next-day British shipping. Vendors market the substance there before redirecting buyers to other platforms for transactions.
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could result in users injecting products of uncertain source.
Several experts said the demand for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.
Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and consumer laws, potentially leading to fines, legal action or imprisonment.
Based on TikTok, the service has taken down violative content and prohibited associated keywords and search suggestions. The organization stated it was dedicated to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Research also found communities with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of members, filled with photos of slimming results, glowing reviews and detailed instructions for mixing or administering at home.
After minutes of joining one group, a vendor shared contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, medical conditions or past usage.
Inside these communities, posts display dark colored packages with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how much time a injector should be used, vendors give conflicting responses varying between a several days to “depends on your body”.
A representative for the messaging service said it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
“People are administering materials they cannot confirm. Even if the research behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.
Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose users to potentially serious health risks”.
A passionate educator and researcher with over a decade of experience in molecular biology and science communication.
